Robert Nelsen, Director, 10% Owner at Prime Medicine, Inc. (PRME), bought 6,128,297 shares at $17.00 ($6.8M) on 2022-10-24, disclosed to the SEC on 2022-10-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 5,728,297 | $0 | 0.0% |
| 2 | $17.00 | 400,000 | $6.8M | 100.0% |
| Total | $1.11 avg | 6,128,297 | $6.8M | 100% |
| Filing → |
| SANA | BUY | 2024-02-12 | $8.0M | — | Filing → |
| NMRA | BUY | 2023-09-29 | $2.1M | — | Filing → |
| NMRA | BUY | 2023-09-27 | $1.0M | — | Filing → |